Corgi | $108,000,000 | (Jan 9, 2026)
Corsera Health | $80,000,000 | (Jan 9, 2026)
Oasys | $4,600,000 | (Jan 9, 2026)
Certified by Founder
Lodge
Scindo
start up
United Kingdom
- London
- 23/09/2025
- Unknown
- $5,403,032
AI-powered enzyme discovery and design enables Scindo to create the next generation of biocatalysts for the future of sustainable manufacturing, transforming industrial chemistry through unprecedented control over selectivity - unlocking novel synthesis routes - while reducing energy, waste, and the reliance on fossil feedstocks. Our enzymes enable direct pathways between natural & renewable, or upcycled feedstocks and bioactive ingredients that are used in your daily lives, from cosmetics & personal care, to nutrients & foods.
- Industry Biotechnology Research
- Website https://www.scindo.bio/
- LinkedIn https://www.linkedin.com/company/scindo/
Vizgen | $48,000,000 | (Jan 9, 2026)
Poplar Therapeutics | $50,000,000 | (Jan 9, 2026)
Carna Health | $8,000,000 | (Jan 9, 2026)
Alveus Therapeutics Inc | $160,000,000 | (Jan 9, 2026)
AgileRL | $7,500,000 | (Jan 9, 2026)
Soley Therapeutics | $200,000,000 | (Jan 9, 2026)
EpiBiologics | $107,000,000 | (Jan 9, 2026)
SpangleAI | $15,000,000 | (Jan 9, 2026)
Presto Phoenix, Inc. | $10,000,000 | (Jan 9, 2026)